Skip to main content

Articles

Conference Highlights ASH

Advances in Cellular Therapies for Hematologic Malignancies Highlighted at ASH 2019

Wayne Kuznar

In the Literature, Oncology

Split-Fill Program for Oncology Oral Medications Is Cost-Saving

Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

Wayne Kuznar

Practice Management

Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy

Phoebe Starr

Multiple Myeloma, Oncology

Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma

Phoebe Starr

Cholangiocarcinoma, Oncology

Surgery for Cholangiocarcinoma

In the Literature, Oncology

Real-World Evidence Supports Patient Navigation in Cancer

Investigational BET Inhibitor, CPI-0610, Promotes Responses in Myelofibrosis

Wayne Kuznar

Corporate Culture of Health: Elusive and Expensive

David B. Nash, MD, MBA

Original Research, Practice Management

Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization

Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH

Stakeholder Perspective

Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?

Atheer A. Kaddis, PharmD

Page 40 of 244
Results 391 - 400 of 2436